Here are four things to know:
1. The matrix-induced autologous chondrocyte implantation uses a patient’s existing cartilage to grow new cartilage, which is then implanted in the knee.
2. MACI involves two procedures. In the first minimally invasive procedure, physicians collect a sample of healthy cartilage cells. The cartilage is grown on the implantable membrane before the more invasive second surgery.
Then physicians clean out damaged cartilage, cut the membrane to match the size of the defect and glue it into place to allow the new cells to migrate to the cartilage.
3. MACI is intended for isolated defects and aimed at a younger, non-arthritic population.
4. Dr. Patel received his medical degree from Cleveland-based Case Western Reserve University School of Medicine and underwent sports medicine and shoulder surgery fellowship training at Durham, N.C.-based Duke University.
More articles on biologics:
Burst Biologics’ umbilical cord blood-derived product is a promising option for spinal fusion, study finds
Orthobiologics market to reach $10.1B by 2025 — 6 key market players
Regenerative medicine company names Susan Vogt to board of directors: 3 notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
